🔺 $AVAX: A COMEBACK DOESN’T NEED A NEW ATH
$AVAX is near $10.4, but the first real test sits at $16.6.
Reclaim that level on a weekly close and hold the retest, and $32.8 becomes the next major resistance to watch.
My broader scenario allows a recovery toward $45–$50, below the $56 historical resistance. That would still leave a lower high within the bigger picture.
The yellow path is a scenario, not a timetable. Rejection at $16.6 would weaken it, while losing the recent $6–$8 base would undermine the recovery.
Nothing is guaranteed. Do Your Own Research.
$AVAX is near $10.4, but the first real test sits at $16.6.
Reclaim that level on a weekly close and hold the retest, and $32.8 becomes the next major resistance to watch.
My broader scenario allows a recovery toward $45–$50, below the $56 historical resistance. That would still leave a lower high within the bigger picture.
The yellow path is a scenario, not a timetable. Rejection at $16.6 would weaken it, while losing the recent $6–$8 base would undermine the recovery.
Nothing is guaranteed. Do Your Own Research.
